Michael Mussallem, chairman and CEO of Irvine, Calif.-based devicemaker Edwards Lifesciences, discusses the company's plans, how his firm demonstrates the value of its products to health systems and the prospects for repeal of the medical-device tax. He spoke with Modern Healthcare reporter Jaimy...
Hospitals are facing higher prices for spinal cord stimulators, used to treat patients with chronic pain, since two manufacturers launched more complex versions of the devices in 2013, according to the Modern Healthcare/ECRI Institute Technology Price Index.
Intuitive Surgical, manufacturer of da Vinci robotic surgery systems, said its net income fell 37% to $418.8 million in 2014 and revenue for the year dropped 6% to $2.13 billion.
Johnson & Johnson reported a 28% drop in net income and flat sales in the fourth quarter of 2014. The income falloff came about because of the impact of unfavorable currency fluctuations along with charges, including integration costs related to the 2012 acquisition of Synthes, and increased...
Medical-equipment manager Universal Hospital Services is suing manufacturer Hill-Rom Holdings for allegedly using its dominance in hospital bed manufacturing to illegally squash competition for equipment rentals.
A drug that's been on the market for decades and is commonly used to treat gout may once again return to the U.S. market with a cheaper price.
Exclusivity deals for hepatitis C drugs by pharmacy benefit managers and a major health plan have raised concerns that the decision of which drug is best for a patient is being taken away from clinicians.
Hospitals in 2015 will continue to search for ways to cut the costs of medical supplies and other nonlabor expenses while developing better methods to measure the value of clinical products.
Omnicare illegally accepted millions of dollars in kickbacks from Abbott Laboratories in exchange for pushing doctors to prescribe a specific drug to dementia patients, the government is alleging in a lawsuit filed Monday against the institutional pharmacy provider.
Tiptoeing into the broader accountability movement, some of the largest medical-device manufacturers are negotiating experimental deals with hospitals to take on performance-based financial risk for their implants.
Chronic illnesses and diseases pose some of the greatest challenges for managing population health. Obesity, for example, affects more than one-third of American adults. Yet its causes are largely due to lifestyle factors that cannot be adequately addressed in just a couple of doctor's visits.
The Ebola scare has subsided in the United States, at least temporarily, but an Alabama manufacturer is still trying to catch up with a glut of orders for gear to protect against the disease.